The subcommittee is seeking documents and information from the FDA and CDC on agency actions, drafts submitted to the White House and changes made during the review process.
A House Oversight subcommittee has requested information about non-expert White House influence at the nation's top health agencies throughout the pandemic.
The allegations of political interference by the White House come at a critical time, particularly for the FDA, which will soon be charged with potentially authorizing the first vaccine for the coronavirus. The subcommittee sent letters to the leaders of the Food and Drug Administration and the Centers for Disease Control and Prevention requesting documents and information on agency actions, drafts submitted to the White House and changes made during the review process.
"We are particularly concerned that a little-known office within the White House — the Office of Information and Regulatory Affairs, part of the Office of Management and Budget — is exerting influence over what is supposed to be non-partisan, scientific messaging," Krishnamoorthi said Tuesday in a statement.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
White House rebuffed CDC offer to lead contact tracing investigation of Trump outbreakThe White House rejected an offer from the CDC - the nation’s public health experts - to lead the effort to track down and notify Americans who were exposed to a growing coronavirus outbreak linked to President Donald Trump and several top aides.
Read more »
White House declines offers from CDC to help with contact tracingThe White House has declined offers from the US Centers for Disease Control and Prevention to help investigate the outbreak surrounding President Donald Trump's Covid-19 diagnosis, according to a federal health official.
Read more »
Trump White House overrules FDA on updated guidelines for vaccine approvalThe White House has blocked new Food and Drug Administration guidelines on bringing potential vaccines for COVID-19 to market that would almost certainly...
Read more »
White House blocks updated FDA guidelines on coronavirus vaccine approvalAt issue was the FDA's planned instruction that vaccine developers follow patients enrolled in their trials for at least two months to rule out safety issues.
Read more »
Report: White House Blocking More Stringent FDA Guidelines On Covid-19 Vaccine ApprovalThe new guidelines call for tracking volunteers in late-stage clinical trials for around two months after the final dose of the vaccine is administered in order to ensure no severe side-effects and adequate immunity from the virus.
Read more »
White House nixes tougher FDA guidelines on vaccine approvalThe White House has blocked new Food and Drug Administration guidelines on bringing potential vaccines for COVID-19 to market that would almost certainly have prevented their approval before the Nov. 3 election
Read more »